Available until October 30, 2014
This webcast is directed primarily to neurologists, neuroradialogists, pharmacists, registered nurses, physician assistants, nurse practitioners and other health care professionals interested in new developments for treatment of multiple sclerosis. No specific skill or knowledge other than a basic training in neurology is required for successful participation in this activity.
This webcast is intended to improve care of patients with multiple sclerosis by accelerating adoption of new guidelines and evidence-based practice change. This webcast will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and MedNet.
This activity is supported by educational grants from: Genzyme, a SANOFI company, Teva Pharmaceuticals and EMD-Serono.